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Abstract
Most neglected tropical diseases (NTDs) have complex life cycles and are challenging to control. The “2020 goals”
of control and elimination as a public health programme for a number of NTDs are the subject of significant
international efforts and investments. Beyond 2020 there will be a drive to maintain these gains and to push for
true local elimination of transmission. However, these diseases are affected by variations in vectors, human
demography, access to water and sanitation, access to interventions and local health systems. We therefore argue
that there will be a need to develop local quantitative expertise to support elimination efforts. If available now,
quantitative analyses would provide updated estimates of the burden of disease, assist in the design of locally
appropriate control programmes, estimate the effectiveness of current interventions and support ‘real-time’ updates
to local operations. Such quantitative tools are increasingly available at an international scale for NTDs, but are
rarely tailored to local scenarios. Localised expertise not only provides an opportunity for more relevant analyses,
but also has a greater chance of developing positive feedback between data collection and analysis by
demonstrating the value of data. This is essential as rational program design relies on good quality data collection.
It is also likely that if such infrastructure is provided for NTDs there will be an additional impact on the health
system more broadly. Locally tailored quantitative analyses can help achieve sustainable and effective control of
NTDs, but also underpin the development of local health care systems.
Background
Neglected tropical diseases (NTDs) are caused by patho-
gens that have successfully overcome the biological chal-
lenges of persistence in the human population (especially
host immunity), but have previously failed to raise a poli-
tical profile that would generate an effective control pro-
gramme (unlike smallpox, HIV etc.). Endemic diseases
typically have a very low profile: TB is perhaps the only
exception of a highly endemic disease with a high politi-
cal profile and therefore substantial research funding.
Almost all NTDs have at least one of a selection of
features that make them hard to control, either by host
immunity, or by public health intervention:
• Poor diagnosis
∘ Resulting in a large proportion of infections
which are clinically indistinct (high asymptomatic
prevalence)
∘ Poor immunological markers (mirroring the
relative ineffectiveness of host immunity)
• Ineffective vaccination
∘ Mirroring the relative ineffectiveness of host
immunity
• Regional high prevalence
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∘ Targeted treatment not feasible or unlikely to
be successful
∘ Asymptomatic infections contribute most to
transmission, creating a rift between clinical
management (which concentrates on the most
sick) and public health (which should concen-
trate on the “infectious well”).
• Maintenance of very low prevalence with spatially
concentrated foci
∘ Mechanisms for maintenance may be unclear
(e.g. Human African Trypanosomiasis, HAT),
perhaps mediated by reservoir hosts or long
infectious periods in asymptomatic hosts
∘ Challenging to break the transmission cycle
• Non-human reservoirs and / or environmental
contamination
∘ Provides a target for control, but often compro-
mised by ubiquity of environmental contamina-
tion / vector density
• Long incubation period and / or low apparent
pathogenicity (i.e. chronic disease rather than acute
death)
∘ Low political profile and interacts with diag-
nostic problems. These are also features which
are highlighted in the chronic and non-commu-
nicable disease discussion papers.
• Transmitted via ubiquitous behaviour
∘ Typically the risk behaviours are essentials (e.g.
washing, sleeping, eating)
• Typically diseases of poor, marginal, populations
with low political profile
∘ This is circular and self-reinforcing in that
these people are compromised by the burden of
disease that they bear.
These characteristics are not solely the characteristics
of the core NTDs, but also other infections which are not
classified as NTDs such as, arguably, Plasmodium vivax
and Plasmodium ovale. NTDs are essentially endemic
diseases in host populations with weak infrastructure
(e.g. sewerage, water purification). Of course, transmis-
sion of several NTDs can be curtailed by improvements
in housing, infrastructure and health systems, as was the
case for soil-transmitted helminths in the USA [1] and
South Korea [2]. It is only since the 1993 World Bank
report [3] that it has been commonly accepted that one
of the reasons for poverty and low infrastructure is the
burden of disease, thus breaking circularity and allowing
NTDs to develop a political profile. It is now generally
accepted that controlling NTDs will facilitate economic
development that will then enable the infrastructure.
Control of NTDs in the absence of massive development
of infrastructure and healthcare facilities, requires multiple
approaches in integrated targeted control programmes.
Technological solutions, or ‘magic bullets’ such as a near
perfect diagnostic or vaccines, can attract funding and
resources, whereas creating broad support for complex
and ‘messy’ solutions from funding agencies, politicians
and affected populations is more challenging. Legal frame-
works and popular perception mean that the efficacy of
individual treatments have to be high, so that vaccines
that provide 30% protection are unlikely to be licenced or
perceived to be successful. However, if they were com-
bined with a behavioural intervention and a targeted treat-
ment programme, they might be an essential element of a
highly successful integrated intervention.
This situation leads to the need to develop local initia-
tives within which programme managers can develop
combination interventions that are consistent with local
behaviours and are culturally acceptable. Examples of
low tech interventions are straining of drinking water
(against dracunculiasis) and insecticide treated bed-nets.
Mixing these interventions with higher tech interven-
tions (such as spraying insecticides, or mass treatment),
can be highly successful, but the details of the culturally
acceptable / appropriate operational aspects have to be
considered in terms of the public health impact. For
example, delivery of mass anthelmintics to school chil-
dren has to be timed with the school year, which might
or might not interact most appropriately with seasonal
transmission. Similarly, insistence on collecting three
sputum specimens to define sputum smear positive was
a global tuberculosis (TB) control requirement but was
of questionable value. Thus, it failed to promote access
to services and in countries where poor people pay sub-
stantial out-of-pocket expenditures to access health
facilities it increased those costs (see CAHRD Paper LH
Costs).
In lower-resource settings efficient allocation of
resources is essential and therefore requires that inter-
ventions have optimal effectiveness within local con-
straints. This will vary considerably at a sub-national
scale, for example between rural and urban areas [4]
and therefore international guidelines are unlikely to be
flexible enough to give advice on appropriate interven-
tions for every setting.
Need for quantitative analysis and modelling
This need for locally applicable solutions using complex
combinations of interventions requires the assistance of
modelling in policy design [5-7]. Modelling has been
used highly successfully in “command and control”
national programmes in developed countries to design
control programmes against childhood viral infections
(MMR) and pandemic influenza [5,8,9]. Modelling has
also been used at national and international scales to
plan for pandemic influenza and advocate for interven-
tions against HIV [10,11]. In a number of high resource
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countries it would now be unacceptable for a vaccina-
tion programme to be proposed for which the appropri-
ate modelling had not been performed to demonstrate
both effectiveness and cost-effectiveness [12,13]. In the
UK, the Joint Committee on Vaccination and Immunisa-
tion (JCVI) has three sentences as its terms of reference,
and the first is: “To advise UK health departments on
immunisations for the prevention of infections and/or
disease following due consideration of the evidence on
the burden of disease, on vaccine safety and efficacy and
on the impact and cost effectiveness of immunisation
strategies” [14]. Its most recent decision on the intro-
duction of a meningitis B vaccine (2014) is based almost
entirely on the cost-effectiveness of the intervention as
predicted by mathematical modelling [15].
Despite the demonstrable usefulness of mathematical
models and quantitative analysis in informing policy,
globally only a small number of countries have the
necessary frameworks and capacity within which model-
ling and policy have developed strong, close relation-
ships that have enabled health policy to be guided by
quantitative models. Clearly, it is not a simple process
to build these relationships, and therefore there is a
need to consider how these tools and expertise can be
developed and used in an effective way to support the
control and elimination of NTDs.
Models are best developed and used in collaboration
with the policy makers and practitioners – to ensure they
are addressing the right questions, making the best use of
all available data and to make sure that the assumptions
and uncertainties in the model are properly communi-
cated [16]. Further, policy makers need support in
becoming intelligent users of models and quantitative
evidence. An additional benefit of bringing modelling
closer to policy and practice is to demonstrate the value
of data collection activities, or of including some ques-
tions in routine surveillance. For example, during the
SARS outbreak in 2003, mathematical epidemiologists
were involved in the design of data collection activities in
Hong Kong, leading to more powerful analyses [17].
For NTDs the need for these models goes beyond the
current 2020 targets [18,19] to long-term control and
true local elimination of transmission, with countries
being increasingly expected to take on the financial
costs (see CAHRD Paper NTD Delivery). There are cur-
rently a whole range of transmission models and novel
statistical analyses being developed (NTD Modelling
Consortium [20], http://www.parasitesandvectors.com/
series/ntdmodels2015, led by the University of
Warwick). There is a marked lack of health systems and
cost-effectiveness modelling in NTD control [21]. The
question which is posed in this discussion paper is how
to bring these tools and insights through to local policy,
including extending from transmission modelling to
health systems and cost-effectiveness modelling.
Bringing quantitative tools to local decision
making
The vision for this discussion paper is that we should
work towards providing mathematical and statistical
tools that can be used to inform and support highly effec-
tive, locally tailored interventions for these highly spa-
tially heterogeneous infections. To be effective these
analyses need to arise as part of an effective co-operation
and collaboration between local stakeholders – commu-
nity representatives, healthcare workers, (national) politi-
cians and epidemiologists (modellers). It requires
modelling teams working locally (sub-nationally), but
located within regional centres of excellence, ideally tied
to local laboratory (surveillance) capacity. This also
requires that modellers overcome hurdles associated with
communicating quantitative sciences to non-specialists,
an issue which affects many aspects of public health, not
just NTDs.
More local modelling has to fit with the roles of local
authorities and community leaders., as well as integrat-
ing with current frameworks. All the components of
health systems will move in one way or another once
any change is effected on any of the building blocks
(human resources, information, financing, governance,
service delivery, etc.). Any move to create local capacity
for NTD modelling should aim to strengthen other
health system components. As data analysis and synthe-
sising and modelling are generally useful to health care
evaluation and planning, such integration is likely to
prove beneficial. To some extent, the structure of such
as system would depend on how NTD is situate within
the organisation.
This network would not be addressing a philosophical
or theoretical need. Programme managers are seeking to
design the best intervention for their population and
regularly ask for guidance on how they should design
complex interventions in their situation. For example
• How well is my intervention working?
• How much longer will I need to hold it in place?
• What combination of interventions should I be
using where?
• What resources and costs will I need to secure
now and in the future?
• What synergies are available between different
interventions?
• What are the opportunity costs of different
interventions?
• What is the impact on patient access and costs?
• How large is the undiagnosed epidemic?
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Of course, although data analysis/synthesis and model-
ling can address the effectiveness aspects of these ques-
tions, economic evaluation is required to address the
cost aspects. This is a major undertaking in itself, and
much of what we have written about modelling could
also be written about economic evaluation: it is context
sensitive and under-resourced, so that supra-national
results are having to be used to make local decisions
(for example, [22]).
Programme managers look to the World Health Orga-
nization (WHO) and other international bodies for gui-
dance, but often there is a need to tailor to local need.
For example, the decision of whether to introduce an
expensive diagnostic depends on local cost-effectiveness
[23]. Local capacity would also address problems of ana-
lysis being done far from the point of need, the need to
keep data and analysis close to the populations to which
they apply and for the analysis to be an active discussion
targeted at improving the local intervention rather than
for academic impact. Modellers would also need to have
a clear understanding of local realities, rather than be led
by pre-conceived ideas of how processes work.
The key to modelling, whatever the scale, is that it is
based on accurate data. Data are always collected locally,
although frequently then collated at a larger scale with
much of the information potentially lost. A likely major
advantage of moving modelling towards the point of data
collection is that the perceived value of the data
increases, which consequently drives up quality, comple-
teness and timeliness, benefitting all levels of analysis.
Another key argument for local modelling is that
NTDs are highly dependent on local ecologies and beha-
viours. Consequently, as national and regional control of
NTDs is achieved, there will be “hot spots” of infection
(as has been seen for malaria [24]) for which general
interventions are insufficient or inappropriate. Following
control and then local elimination, intervention pro-
grams maybe halted, but on-going well-designed surveil-
lance and monitoring will be required to maintain these
gains. Ultimately all NTD elimination will be local, so
developing a local capacity now is both providing the
opportunity to improve the design of current interven-
tions and improving preparation for the “final mile” and
true elimination. This requires not only good transmis-
sion modelling, but also better models of health systems.
If this can be done for NTDs it can also strengthen
capacity and health systems with positive effects for
public health more generally.
The LSTM/Warwick collaboration
The collaboration between LSTM and the University of
Warwick provides a unique opportunity to develop this
vision. Warwick Infectious Disease Epidemiology
Research (WIDER) is an internationally renowned centre
for infectious disease modelling, with experience in
training modellers through undergraduate, graduate and
extra-mural courses. The team at Warwick has consid-
erable experience in training modellers and can provide
an international resource and underpin local capacity in
development of modelling frameworks. LSTM and its
global partners have the international experience in sup-
porting capacity strengthening (see CAHRD Paper HS
Capacity) and in delivering interventions to improve
health systems. LSTM has played a role throughout the
pathway from basic research through to new tools,
which lead to new strategies. They have experience in
NTD data collection and intervention evaluation, but
more importantly the expertise to provide the experi-
ence of cultural sensitivity to design management sys-
tems required to adapt interventions to local settings.
Local interventions should be designed by locals, but
this requires a framework and structures that are able to
combine the hard sciences of modelling and data analy-
sis with the softer sciences of sociological, economic
and political management. Such integrated tools sup-
port:
1. Planning policy and predicting impact of
interventions.
2. Estimating current state, interpreting surveillance
data and predicting effectiveness of interventions.
3. Identifying the most effective way to roll-out
interventions.
4. Calculating cost-effectiveness of interventions
within local settings.
Issues to be discussed
There are a number of questions which need to be
addressed in providing these tools and capacity. They
include, but are not limited to, the following:
A Technical questions
1. What level of expert knowledge should be
required to run the modelling tools and statistical
analyses? Should there be an automatic interac-
tion with decision management tools, maps etc.
This will depend on the functionality required and the
disease being modelled. An automated tool has many
benefits in terms of rapidity of results and analyses and
ease of use and integration with decision support tools
(see CAHRD Paper NTD Tools). There are risks asso-
ciated with fully automated tools, however, including loss
of faith in the results when incorrectly used or inter-
preted and risks of the “wrong” model being used if not
done automatically. Therefore, even with automated
tools, local expertise has to be sufficiently expert. The
choice between fully automated and more “hands-on”
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tools will be a delicate balance between giving the tools
to the local decision makers and making sure quality is
maintained. It is therefore important to involve both
modellers and stakeholders in the design of any inter-
faces.
2. Should one model or multiple models be used
at the programmatic level?
As recognised with the NTD Modelling Consortium,
there is a need for multiple models scientifically and at
strategic level, but are they needed at the programmatic
level? Using multiple models can create a false sense of
security if they are actually very similar models and it can
be difficult for a non-expert to interpret differences
between models. But it may be important to highlight
these differences. Perhaps it would be possible to develop
a new approach to determining which of a suite of mod-
els is most appropriate for different circumstances. At
present there can be argument about which is the “best”
model – but the real question is which is the most “use-
ful” model – or even better, which is the most “useful
result”. It is important to remember that modelling is
only a means to an end: use of the modelling results, and
their impact on policy and interventions, are the end
points.
3. How local is local?
There is clearly an epidemiological / ecological spatial
scale for these diseases, but there are also political and
social scales, which frequently do not overlap neatly -
national and regional boundaries were not designed to
make infectious disease control easy. Therefore the level
at which these models need to be used will depend on
the disease and location for which they are being devel-
oped. This question also addresses how human expertise
should be distributed, from international to local levels:
is there sufficient resource for a talented modeller at
each location, or should modellers be national, with bio-
metricians more locally?
B Finding the right mechanisms
4. What does previous experience tell us?
There are two major centres for infectious disease
modelling in middle-income countries. The first is the
South African Centre for Epidemiological Modelling and
Analysis (SACEMA), which provides epidemiological
modelling analyses for a number of African countries,
with a particular strength in HIV and tsetse-borne try-
panosomiasis. The second is the Mathematical and Epi-
demiological Modelling unit (MAEMOD) at the
Mahidol-Oxford Tropical Medicine Research Unit in
Bangkok, Thailand. Both have many years of applying
epidemiological modelling to low-resource countries and
building regional capacity.
5. What is the right mechanism for generating
demand, developing capacity, supporting
capacity?
This depends on what level of skills are required,
whether it is short-term training courses through to doc-
toral or post-doctoral training and exchanges. It also
depends on the extent to which different levels of local
policy makers need to be informed about the interpreta-
tion and use of models. There is also a need to frame the
capacity development in terms of overall capacity
strengthening, with explicit goals and processes (see
CAHRD Paper HS Capacity).
6. What should we prioritise?
Commonalities between different modelling
approaches and methodologies should mean that by
building the models which policy-makers need for one
disease and training people on one area of modelling will
impact others, both within and outside NTDs (see
CAHRD Paper HS Capacity). Depending on local need,
or availability of data, human capacity or other resources,
LSTM/Warwick may be able to assist in different areas in
different countries. In some countries it may be best to
prioritise those NTDs for which mass drug administra-
tion planning is urgently required, whilst in others it may
be best to start with outbreak analysis for diseases such
as HAT.
Summary
The 2020 goals for NTD are highly laudable and will
deliver huge public health impacts across the NTDs
[18,19]. Models are an essential tool in planning policy
and estimating the resources required and the timescales
over which targets can be achieved. However, over the
10-20 year timescale, breaking transmission cycles for
some of these diseases is going to be extremely challen-
ging, and true elimination may require special measures,
and might even be beyond current technology and com-
petence (see CAHRD Paper NTD Tools). Control and
elimination will require complex combinations of inter-
ventions tailored to local need and social context, as
highlighted in the other discussion papers (see CAHRD
Papers NTD Tools and Delivery), and to the local social
context. Quantitative analyses will be an essential part
of adapting these programmes in the most effective way
- the analyses and modelling that have become standard
for developed countries should be made available more
widely. Developing this capacity will also have impact
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on health systems more broadly, enabling local health
systems to add an additional skillset to improve health
outcomes. Investment in NTD control and elimination
programs, aligned with a general strengthening of health
systems, will leave a valuable legacy that goes beyond
the primary aim of controlling these diseases.
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